UBS raises target for RELX stock as AI supports growth

Published on 10/27/2026 at 11:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS lifted its target to GBp 3,780 from GBp 3,600 on October 26, 2026. RELX stock trades at EUR 36.07 on October 27, 2026.

Targets and operating growth

UBS raised its RELX target from GBp 3,600 to GBp 3,780 on October 26, 2026.
Underlying revenue grew 7.00 percent in the first nine months of 2026.
RELX stock trades at EUR 36.07 at 11:12 a.m. CET at Lang & Schwarz on October 27, 2026.
The next STM investor seminar is scheduled for November 3, 2026.

RELX, GB00B2B0DG97, Illustration mit AI erstellt.

RELX stock (ISIN GB00B2B0DG97) trades at EUR 36.07 at Lang & Schwarz on October 27, 2026 at 11:12 a.m. CET. UBS raised its target to GBp 3,780 from GBp 3,600 and kept its Buy rating on October 26, 2026, according to Proactive.

AI demand supports the update

RELX reported 7.00 percent underlying revenue growth for the first nine months of 2026 and reaffirmed its full-year outlook. The company also announced a GBP 125.0 million share buyback running through December 2, 2026, following completion of an earlier GBP 125.0 million program, as MarketScreener reported on October 22, 2026.

The operating mix gives the growth figure more substance. Legal revenue rose 10.00 percent, Risk increased 8.00 percent and Scientific, Technical & Medical grew 6.00 percent in the same nine-month period, while Exhibitions advanced 4.00 percent and faced Middle East disruption.

What does the target mean?

UBS paired its higher target with a counter-factor: it cut its 2026 Exhibitions growth forecast to 4.00 percent from 7.00 percent because of regional disruption. The broker said adoption of AI products in Legal and Risk is increasingly supporting demand, while monetization of the LeapSpace scientific research platform remains a longer-term opportunity.

Three recent stock events

On October 20, 2026, Citi moved RELX to Neutral from Buy and lifted its target to GBp 3,125 from GBp 2,870, according to the finance report. On October 22, 2026, RELX reported 7.00 percent nine-month underlying revenue growth. On October 26, 2026, UBS raised its target from GBp 3,600 to GBp 3,780.

Important dates ahead

RELX's next substantiated dates are the STM investor seminar on November 3, 2026, and the current GBP 125.0 million buyback program's stated end date of December 2, 2026.

Stock price and company profile

RELX is a London-based provider of information-based analytics and decision tools. Its shares trade in London under ticker REL, in Amsterdam under REN and in New York under RELX, according to the company's investor information.

The stock was trading at EUR 36.07 at Lang & Schwarz on October 27, 2026 at 11:12 a.m. CET. The further course of trading is shown by the continuously updated real-time quote of RELX stock.